GenIP (LSE:GNIP) reported unaudited interim results for the first half of 2026, recording revenue of $53,000 and an adjusted EBITDA loss of $692,000 as the company continued investing in its platform and commercial activities.

The AIM-listed company reported a gross margin of 6% and held $410,000 in cash at the end of the period.

Management said the first-half performance reflected GenIP’s early stage of development and ongoing investment in its products and commercial operations.

GenIP expands client and geographic coverage

During the period, GenIP reported increased adoption of its services and additional repeat business from existing clients.

The company also expanded its activities in Asia and Latin America and entered into a strategic alliance with Cardinal Intellectual Property aimed at increasing its access to the U.S. market.

GenIP provides AI-based services designed to help companies, venture funds and research organisations evaluate and commercialise technologies. Its offerings include an AI-powered Invention Intelligence product suite and intellectual property commercialisation services.

April fundraise brings in $470,000

GenIP raised $470,000 in April, with the proceeds intended to support platform development, the commercialisation of partnerships and further product enhancements.

Since the end of the reporting period, the company has secured additional orders in Chile, the U.K. and North America.

GenIP has also obtained a new Talent Search engagement as part of its ongoing repositioning.

Management points to underlying operating indicators

Management said underlying indicators were improving despite the absence of a one-off contract that contributed to the comparative period.

The company is targeting customers including academic institutions, government innovation organisations and corporate research and development teams.

GenIP said its strategy is focused on providing structured, data-driven innovation intelligence tools as governments and companies increase investment in innovation programmes.

The company continues to develop its products and partnerships while expanding its commercial activities across international markets.